ALS Worldwide welcomes any questions or comments you might have.  We provide free, personalized and confidential support services to anyone in the ALS community—whether you are a patient or a loved one, friend, health care professional or caregiver of someone diagnosed.

Get help now! Fill out the Online Profile Form or if you would prefer to talk with someone by email or phone first, please contact us at [email protected] or 1-608-663-0920.

For all other inquiries, please use the email form to the right and we will respond promptly to your request.Thank you.

ALS Worldwide
5808 Dawley Drive
Fitchburg, WI 53711‑7209

ALS Worldwide
Sorted by category: Medications | View All
March 27, 2017

Masitinib & Edaravone: Two Proven ALS Drugs Await Simultaneous FDA Approval

Masitinib And Edaravone: Two Proven ALS Drugs Await Simultaneous FDA Approval.

September 01, 2016

RADICAVA™ (edaravone)

The FDA May approve the first ALS treatment in over 20 years.

February 22, 2016

MicroNeurotrophins: An Introduction

A brief overview of MicroNeurotrophins, a set of promising drugs to treat ALS/MND and other neurodegenerative diseases.

February 03, 2016

About Methyl B12

Injectable high dosage Methylcobalamin, liquid vitamin B12 has proven beneficial for hundreds of ALS/MND patients. Developed in Japan, it is now in worldwide use.

January 12, 2016

Nuedexta - Improving Quality of Life for ALS/MND Patients

Nuedexta, known for minimizing psuedo-bulbar affect, also is now recommended for improving chewing and swallowing, control of facial muscles, speech, and respiration.

December 15, 2015

Important Study Developments from the 2015 ALS/MND Symposium

Endorsements from the medical community have arrived! Methylcobalamin, Nuedexta and the Diaphragm Pacer surgery improve quality of life and extend survival.